A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 22, 2017

Primary Completion Date

July 14, 2022

Study Completion Date

July 14, 2022

Conditions
Pancreatic Ductal Adenocarcinoma
Interventions
PROCEDURE

Irreversible Electroporation

Irreversible electroporation (IRE) is a process that uses the NanoKnife system to sent electrical currents to a cancer tumor which will disrupt the tumor cell and therefore causing the cell to die. Eligible patients will undergo in situ IRE performed via laparotomy surgery.

DEVICE

NanoKnife System

A system consisting of electrode probes connected to a machine. The probes will be surgically placed around the tumor.

Trial Locations (1)

M5G 2M9

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT03257150 - A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer | Biotech Hunter | Biotech Hunter